Covington has advised OrbiMed. Goodwin Procter has advised Intellia Therapeutics. OrbiMed, a global healthcare investment firm, has entered into a non-dilutive senior secured term loan facility...
OrbiMed Provides $400 Million Non-Dilutive Debt Facility to Intellia Therapeutics
Myriad Genetics Secures $200 Million Credit Facility
Covington has advised OrbiMed on the transaction. OrbiMed, a leading global healthcare investment firm, has provided a five-year senior secured term loan credit facility of up...
Oberland Capital’s Investment in ClearPoint Neuro
Covington & Burling advised ClearPoint Neuro on the transaction, Sheppard, Mullin, Richter & Hampton advised ClearPoint Neuro on the registered direct offering, and Cooley advised Oberland...
Oberland Capital’s $600 Million Investment in Biohaven
Covington & Burling advised Biohaven Ltd. on the transaction, and Cooley advised Oberland Capital. Biohaven Ltd. (NYSE: BHVN) announced it has entered into an agreement with...
OrbiMed’s $50 Million Financing
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
MidFirst Bank’s Acquisition of Amerant Banks Houston Locations
Covington & Burling represented MidFirst Bank, and Squire Patton Boggs represented Amerant Bancorp Inc. Amerant Bancorp Inc. (NYSE: AMTB) (“Amerant” or the “Company”) announced that its...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
OrbiMed’s $125 Million Debt Financing
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
OrbiMed’s $75 Million Debt Financing
Covington advised OrbiMed on the deal. An investment fund affiliated with OrbiMed Advisors announced a $75 million delayed draw senior secured loan to be provided to...
Caris Life Sciences’ $400 Million Secured Debt Financing
Covington advised OrbiMed on the deal. OrbiMed acted as the lead investor in a $400 million senior secured term loan facility provided to Caris Life Sciences, a...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...